{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:08:59Z","timestamp":1790298539593,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602150"],"award-info":[{"award-number":["602150"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To study variation in, and clinical impact of high Therapy Intensity Level (TIL) treatments for elevated intracranial pressure (ICP) in patients with traumatic brain injury (TBI) across European Intensive Care Units (ICUs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We studied high TIL treatments (metabolic suppression, hypothermia (&lt;\u200935\u00a0\u00b0C), intensive hyperventilation (PaCO\n                      <jats:sub>2<\/jats:sub>\n                      \u2009&lt;\u20094\u00a0kPa), and secondary decompressive craniectomy) in patients receiving ICP monitoring in the ICU stratum of the CENTER-TBI study. A random effect logistic regression model was used to determine between-centre variation in their use. A propensity score-matched model was used to study the impact on outcome (6-months Glasgow Outcome Score-extended\u00a0(GOSE)), whilst adjusting for case-mix severity, signs of brain herniation on imaging, and ICP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>313 of 758 patients from 52 European centres (41%) received at least one high TIL treatment with significant variation between centres (median odds ratio\u2009=\u20092.26). Patients often transiently received high TIL therapies without escalation from lower tier treatments. 38% of patients with high TIL treatment had favourable outcomes (GOSE\u2009\u2265\u20095). The use of high TIL treatment was not significantly associated with worse outcome (285 matched pairs, OR 1.4, 95% CI [1.0\u20132.0]). However, a sensitivity analysis excluding high TIL treatments at day 1 or use of metabolic suppression at any day did reveal a statistically significant association with worse outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Substantial between-centre variation in use of high TIL treatments for TBI was found and treatment escalation to higher TIL treatments were often not preceded by more conventional lower TIL treatments. The significant association between high TIL treatments after day 1 and worse outcomes may reflect aggressive use or unmeasured confounders or inappropriate escalation strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Take home message<\/jats:title>\n                    <jats:p>Substantial variation was found in the use of highly intensive ICP-lowering treatments across European ICUs and a stepwise escalation strategy from lower to higher intensity level therapy is often lacking. Further research is necessary to study the impact of high therapy intensity treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>\n                      <jats:italic>Trial registration<\/jats:italic>\n                    <\/jats:title>\n                    <jats:p>\n                      The core study was registered with ClinicalTrials.gov, number NCT02210221, registered 08\/06\/2014,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02210221?id=NCT02210221&amp;draw=1&amp;rank=1\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02210221?id=NCT02210221&amp;draw=1&amp;rank=1<\/jats:ext-link>\n                      and with Resource Identification Portal (RRID: SCR_015582).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-020-03370-y","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T12:10:07Z","timestamp":1614082207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Use and impact of high intensity treatments in patients with traumatic brain injury across Europe: a CENTER-TBI analysis"],"prefix":"10.1186","volume":"25","author":[{"name":"the CENTER-TBI investigators and participants","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-5406","authenticated-orcid":false,"given":"Jilske A.","family":"Huijben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Stocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I. R.","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester F.","family":"Lingsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"van der Jagt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Ercole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"issue":"6","key":"3370_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3171\/jns.1987.67.6.0832","volume":"67","author":"AL Maset","year":"1987","unstructured":"Maset AL, Marmarou A, Ward JD, Choi S, Lutz HA, Brooks D, Moulton RJ, DeSalles A, Muizelaar JP, Turner H, et al. Pressure-volume index in head injury. J Neurosurg. 1987;67(6):832\u201340.","journal-title":"J Neurosurg"},{"issue":"7","key":"3370_CR2","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1097\/01.CCM.0000220765.22184.ED","volume":"34","author":"PM Shore","year":"2006","unstructured":"Shore PM, Hand LL, Roy L, Trivedi P, Kochanek PM, Adelson PD. Reliability and validity of the pediatric intensity level of therapy (PILOT) scale: a measure of the use of intracranial pressure-directed therapies. Crit Care Med. 2006;34(7):1981\u20137.","journal-title":"Crit Care Med"},{"issue":"19","key":"3370_CR3","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1089\/neu.2015.4266","volume":"33","author":"P Zuercher","year":"2016","unstructured":"Zuercher P, Groen JL, Aries MJ, Steyerberg EW, Maas AI, Ercole A, Menon DK. Reliability and validity of the therapy intensity level scale: analysis of clinimetric properties of a novel approach to assess management of intracranial pressure in traumatic brain injury. J Neurotrauma. 2016;33(19):1768\u201374.","journal-title":"J Neurotrauma"},{"issue":"4","key":"3370_CR4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/CCM.0000000000002263","volume":"45","author":"MC Cnossen","year":"2017","unstructured":"Cnossen MC, Polinder S, Andriessen TM, van der Naalt J, Haitsma I, Horn J, Franschman G, Vos PE, Steyerberg EW, Lingsma H. Causes and consequences of treatment variation in moderate and severe traumatic brain injury: a multicenter study. Crit Care Med. 2017;45(4):660\u20139.","journal-title":"Crit Care Med"},{"issue":"8","key":"3370_CR5","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1097\/00003246-200208000-00033","volume":"30","author":"EM Bulger","year":"2002","unstructured":"Bulger EM, Nathens AB, Rivara FP, Moore M, MacKenzie EJ, Jurkovich GJ, Brain Trauma F. Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med. 2002;30(8):1870\u20136.","journal-title":"Crit Care Med"},{"issue":"12","key":"3370_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1605215","volume":"375","author":"PJ Hutchinson","year":"2016","unstructured":"Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, Anderson I, Bulters DO, Belli A, Eynon CA, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375(12):1119\u201330.","journal-title":"N Engl J Med"},{"issue":"21","key":"3370_CR7","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2018.17075","volume":"320","author":"DJ Cooper","year":"2018","unstructured":"Cooper DJ, Nichol AD, Bailey M, Bernard S, Cameron PA, Pili-Floury S, Forbes A, Gantner D, Higgins AM, Huet O, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial. JAMA. 2018;320(21):2211\u201320.","journal-title":"JAMA"},{"issue":"16","key":"3370_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJMoa1102077","volume":"364","author":"DJ Cooper","year":"2011","unstructured":"Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D\u2019Urso P, Kossmann T, Ponsford J, Seppelt I, Reilly P, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364(16):1493\u2013502.","journal-title":"N Engl J Med"},{"key":"3370_CR9","unstructured":"Steyerberg EW ea: The contemporary landscape of traumatic brain injury in Europe: Case-mix, care pathways, and outcomes from the CENTER-TBI study. Lancet neurology 2019."},{"issue":"1","key":"3370_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1227\/NEU.0000000000000575","volume":"76","author":"AI Maas","year":"2015","unstructured":"Maas AI, Menon DK, Steyerberg EW, Citerio G, Lecky F, Manley GT, Hill S, Legrand V, Sorgner A, Participants C-T, et al. Collaborative European neurotrauma effectiveness research in traumatic brain injury (CENTER-TBI): a prospective longitudinal observational study. Neurosurgery. 2015;76(1):67\u201380.","journal-title":"Neurosurgery"},{"key":"3370_CR11","doi-asserted-by":"crossref","unstructured":"Van Buuren S. G-OK: mice: Multivariate Imputation by Chained Equations in R. J Stat Softw 45. 2011.","DOI":"10.18637\/jss.v045.i03"},{"issue":"8","key":"3370_CR12","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1371\/journal.pmed.0050165","volume":"5","author":"EW Steyerberg","year":"2008","unstructured":"Steyerberg EW, Mushkudiani N, Perel P, Butcher I, Lu J, McHugh GS, Murray GD, Marmarou A, Roberts I, Habbema JD, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med. 2008;5(8):e165.","journal-title":"PLoS Med"},{"issue":"4","key":"3370_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1136\/jech.2004.029454","volume":"60","author":"J Merlo","year":"2006","unstructured":"Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, Rastam L, Larsen K. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60(4):290\u20137.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"3370_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s12028-018-0590-0","volume":"30","author":"RH Bonow","year":"2019","unstructured":"Bonow RH, Quistberg A, Rivara FP, Vavilala MS. Intensive care unit admission patterns for mild traumatic brain injury in the USA. Neurocrit Care. 2019;30(1):157\u201370.","journal-title":"Neurocrit Care"},{"issue":"5","key":"3370_CR15","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/ije\/dyx180","volume":"46","author":"D Doiron","year":"2017","unstructured":"Doiron D, Marcon Y, Fortier I, Burton P, Ferretti V. Software application profile: opal and mica: open-source software solutions for epidemiological data management, harmonization and dissemination. Int J Epidemiol. 2017;46(5):1372\u20138.","journal-title":"Int J Epidemiol"},{"issue":"Suppl 1","key":"3370_CR16","first-page":"S1","volume":"24","author":"F Brain Trauma","year":"2007","unstructured":"Brain Trauma F. American association of neurological s, congress of neurological s: guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(Suppl 1):S1-106.","journal-title":"J Neurotrauma"},{"issue":"9","key":"3370_CR17","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s00134-008-1123-7","volume":"34","author":"JO Neumann","year":"2008","unstructured":"Neumann JO, Chambers IR, Citerio G, Enblad P, Gregson BA, Howells T, Mattern J, Nilsson P, Piper I, Ragauskas A, et al. The use of hyperventilation therapy after traumatic brain injury in Europe: an analysis of the BrainIT database. Intensive Care Med. 2008;34(9):1676\u201382.","journal-title":"Intensive Care Med"},{"issue":"4","key":"3370_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3171\/jns.2006.104.4.469","volume":"104","author":"B Aarabi","year":"2006","unstructured":"Aarabi B, Hesdorffer DC, Ahn ES, Aresco C, Scalea TM, Eisenberg HM. Outcome following decompressive craniectomy for malignant swelling due to severe head injury. J Neurosurg. 2006;104(4):469\u201379.","journal-title":"J Neurosurg"},{"key":"3370_CR19","doi-asserted-by":"crossref","unstructured":"Roberts I, Sydenham E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2012, 12:CD000033.","DOI":"10.1002\/14651858.CD000033.pub2"},{"issue":"9","key":"3370_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5694\/j.1326-5377.2011.tb03053.x","volume":"194","author":"DJ Cooper","year":"2011","unstructured":"Cooper DJ, Rosenfeld JV. Does decompressive craniectomy improve outcomes in patients with diffuse traumatic brain injury? Med J Aust. 2011;194(9):437\u20138.","journal-title":"Med J Aust"},{"issue":"25","key":"3370_CR21","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1056\/NEJMoa1507581","volume":"373","author":"PJ Andrews","year":"2015","unstructured":"Andrews PJ, Sinclair HL, Rodriguez A, Harris BA, Battison CG, Rhodes JK, Murray GD, Eurotherm Trial C. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015;373(25):2403\u201312.","journal-title":"N Engl J Med"},{"issue":"1","key":"3370_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13054-017-1816-9","volume":"21","author":"MC Cnossen","year":"2017","unstructured":"Cnossen MC, Huijben JA, van der Jagt M, Volovici V, van Essen T, Polinder S, Nelson D, Ercole A, Stocchetti N, Citerio G, et al. Variation in monitoring and treatment policies for intracranial hypertension in traumatic brain injury: a survey in 66 neurotrauma centers participating in the CENTER-TBI study. Crit Care. 2017;21(1):233.","journal-title":"Crit Care"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-020-03370-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T12:10:17Z","timestamp":1614082217000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03370-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3370"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03370-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-69288\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]},"assertion":[{"value":"7 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In each recruiting site ethical approval was given; an overview is available online (\n                      \n                      ).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AIRM declares consulting fees from PresSura Neuro, Integra Life Sciences, and NeuroTrauma Sciences. DKM reports grants from the UK National Institute for Health Research, during the conduct of the study; grants, personal fees, and non-financial support from GlaxoSmithKline; personal fees from Neurotrauma Sciences, Lantmaanen AB, Pressura, and Pfizer, outside of the submitted work. WP reports grants from the Netherlands Brain Foundation. ES reports personal fees from Springer, during the conduct of the study. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}